IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells

European Journal of Immunology

Volumn 43, Issue 7, 2013, Pages 1896-1906

  Steinhagen, Folkert ^a,d   Mcfarland, Adelle P ^a,e   Rodriguez, Luis G ^b   Tewary, Poonam ^c   Jarret, Abigail ^e   Savan, Ram ^a,e   Klinman, Dennis M ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b SAIC FREDERICK INC   (United States)

^c Developmental Therapeutics Program   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CpG oligonucleotide; Dendritic cell; IRF 5; NF B; TLR9

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 6; NF KAPPA B P50; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

CPG OLIGONUCLEOTIDE; DENDRITIC CELL; IRF-5; NF-ΚB; TLR9;

CELL LINE; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTORS; INTERFERON-BETA; INTERLEUKIN-6; NF-KAPPA B P50 SUBUNIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 9;

EID: 84880026840     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242792     Document Type: Article

References (60)

1. Kawai, T.and Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010. 11: 373-384.
2. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F.and Lanzavecchia, A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 3388-3393.
3. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F.and Liu, Y. J., Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001. 194: 863-869.
4. Haining, W. N., Davies, J., Kanzler, H., Drury, L., Brenn, T., Evans, J., Angelosanto, J. et al., CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans. Clin. Cancer Res. 2008. 14: 5626-5634.
5. Steinhagen, F., Kinjo, T., Bode, C.and Klinman, D. M., TLR-based immune adjuvants. Vaccine 2011. 29: 3341-3355.
6. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S. Antonenko, S., et al., The nature of the principal type 1 interferon-producing cells in human blood. Science 1999. 284: 1835-1837.
7. Gallucci, S., Lolkema, M.and Matzinger, P., Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999. 11: 1249-1255.
8. Kato, A., Homma, T., Batchelor, J., Hashimoto, N., Imai, S., Wakiguchi, H. Saito, H., et al., Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 2003. 4: 8.
9. Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T. et al., Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 2003. 170: 4465-4474.
10. Gray, R. C., Kuchtey, J.and Harding, C. V., CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs. J. Leukoc. Biol. 2007. 81: 1075-1085.
11. Jones, S. A., Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 2005. 175: 3463-3468.
12. Steinhagen, F., Meyer, C., Tross, D., Gursel, M., Maeda, T., Klaschik, S.and Klinman, D. M., Activation of type I interferon dependent genes characterizes the 'core response' induced by CpG DNA. J. Leukoc. Biol. 2012. 92:775-785.
13. Fitzgerald-Bocarsly, P., Dai, J.and Singh, S., Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008. 19: 3-19.
14. Takeshita, F., Ishii, K. J., Ueda, A., Ishigatsubo, Y.and Klinman, D. M., Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression. Eur. J. Immunol. 2000. 30: 108-116.
15. Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S. et al., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005. 434: 243-249.
16. Schmitz, F., Heit, A., Guggemoos, S., Krug, A., Mages, J., Schiemann, M., Adler, H. et al., Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 2007. 37: 315-327.
17. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. et al., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005. 434: 1035-1040.
18. Sasai, M., Linehan, M. M.and Iwasaki, A., Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 2010. 329: 1530-1534.
19. Kaiser, F., Cook, D., Papoutsopoulou, S., Rajsbaum, R., Wu, X., Yang, H. T., Grant, S. et al., TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells. J. Exp. Med. 2009. 206: 1863-1871.
20. Schroder, K., Spille, M., Pilz, A., Lattin, J., Bode, K. A., Irvine, K. M., Burrows, A. D. et al., Differential effects of CpG DNA on IFN-beta induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages. J. Immunol. 2007. 179: 3495-3503.
21. Cisse, B., Caton, M. L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D. et al., Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008. 135: 37-48.
22. Maeda, T., Murata, K., Fukushima, T., Sugahara, K., Tsuruda, K., Anami, M., Onimaru, Y. et al., A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma. Int. J. Hematol. 2005. 81: 148-154.
23. Flesher, D. L., Sun, X., Behrens, T. W., Graham, R. R.and Criswell, L. A., Recent advances in the genetics of systemic lupus erythematosus. Expert. Rev. Clin. Immunol. 2010. 6: 461-479.
24. Deng, Y.and Tsao, B. P., Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 2010. 6: 683-692.
25. Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W. et al., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 2009. 41: 1228-1233.
26. Salloum, R.and Niewold, T. B., Interferon regulatory factors in human lupus pathogenesis. Transl. Res. 2011. 157: 326-331.
27. Sigurdsson, S., Nordmark, G., Goring, H. H., Lindroos, K., Wiman, A. C., Sturfelt, G., Jonsen, A. et al., Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 2005. 76: 528-537.
28. De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I., Ottoboni, L., Aggarwal, N. T., Piccio, L. et al., Meta-analysis of genome scans and replication identify CD6, IRF-8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009. 41: 776-782.
29. Tamura, T., Yanai, H., Savitsky, D.and Taniguchi, T., The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008. 26: 535-584.
30. Ghosh, S.and Hayden, M. S., New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008. 8: 837-848.
31. Hacker, H., Vabulas, R. M., Takeuchi, Hoshino, K., Akira, S.and Wagner, H., Immune cell activation by bacterial CpG-DNA through myeroid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 2000. 192: 595-600.
32. Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A. et al., The interferon regulatory factor, IRF-5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 2005. 280: 17005-17012.
33. Vallabhapurapu, S.and Karin, M., Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009. 27: 693-733.
34. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. et al., Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005. 11: 263-270.
35. Tailor, P., Tamura, T., Kong, H. J., Kubota, T., Kubota, M., Borghi, P., Gabriele, L. et al., The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007. 27: 228-239.
36. Tamura, T., Tailor, P., Yamaoka, K., Kong, H. J., Tsujimura, H., O'Shea, J. J., Singh, H. et al., IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 2005. 174: 2573-2581.
37. Tsujimura, H., Tamura, T., Kong, H. J., Nishiyama, A., Ishii, K. J., Klinman, D. M.and Ozato, K., Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 2004. 172: 6820-6827.
38. Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y. et al., Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004. 101: 15416-15421.
39. Jiang, Z., Georgel, P., Li, C., Choe, J., Crozat, K., Rutschmann, S., Du, X. et al., Details of Toll-like receptor: adapter interaction revealed by germ-line mutagenesis. Proc. Natl. Acad. Sci. USA 2006. 103: 10961-10966.
40. Soderberg, O., Gullberg, M., Jarvius, M., Ridderstrale, K., Leuchowius, K. J., Jarvius, J., Wester, K. et al., Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Met. 2006. 3: 995-1000.
41. Gilliet, M., Cao, W.and Liu, Y. J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008. 8: 594-606.
42. Klinman, D. M., Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 2004. 4: 249-258.
43. Halperin, S. A., Dobson, S., McNeil, S., Langley, J. M., Smith, B., Call-Sani, R., Levitt, D. et al., Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. Vaccine 2006. 24: 20-26.
44. Rynkiewicz, D., Rathkopf, M., Sim, I., Waytes, A.T., Hopkins, R.J., Giri, L., DeMuria D. et al., Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers. Vaccine 2011. 29: 6313-6320.
45. Paun, A., Reinert, J. T., Jiang, Z., Medin, C., Balkhi, M. Y., Fitzgerald, K. A.and Pitha, P. M., Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 2008. 283: 14295-14308.
46. Hemmi, H., Takeuchi, O., Kawai, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K. et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
47. Mancl, M. E., Hu, G., Sangster-Guity, N., Olshalsky, S. L., Hoops, K., Fitzgerald-Bocarsly, P., Pitha, P. M. et al., Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 2005. 280: 21078-21090.
48. Seth, R. B., Sun, L., Ea, C. K.and Chen, Z. J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF- 3. Cell 2005. 122: 669-682.
49. Liu, Y. C., Gray, R. C., Hardy, G. A., Kuchtey, J., Abbott, D. W., Emancipator, S. N.and Harding, C. V., CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells. J. Immunol. 2010. 184: 3367-3376.
50. Levi, B. Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A.and Meraro, D., ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J Interferon Cytokine Res. 2002. 22: 153-160.
51. Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R.and Levi, B. Z., Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 1995. 270: 13063-13069.
52. Li, P., Wong, J. J., Sum, C., Sin, W. X., Ng, K. Q., Koh, M. B.and Chin, K. C., IRF-8 and IRF-3 cooperatively regulate rapid interferon-beta induction in human blood monocytes. Blood 2011. 117: 2847-2854.
53. Seshadri, S., Kannan, Y., Mitra, S., Parker-Barnes, J.and Wewers, M. D., MAIL regulates human monocyte IL-6 production. J. Immunol. 2009. 183: 5358-5368.
54. Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T. et al., Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004. 430: 218-222.
55. Totzke, G., Essmann, F., Pohlmann, S., Lindenblatt, C., Janicke, R. U.and Schulze-Osthoff, K., A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 2006. 281: 12645-12654.
56. Jarvinen, T. M., Hellquist, A., Zucchelli, M., Koskenmies, S., Panelius, J., Hasan, T., Julkunen, H. et al., Replication of genome-wide association study identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF-5 in disease susceptibility in a Northern European population. Rheumatology (Oxford) 2011. 51: 87-92.
57. Eloranta, M. L., Franck-Larsson, K., Lovgren, T., Kalamajski, S., Ronnblom, A., Rubin, K., Alm, G. V. et al., Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann. Rheum. Dis. 2010. 69: 1396-1402.
58. Yasuda, K., Richez, C., Uccellini, M. B., Richards, R. J., Bonegio, R. G., Akira, S., Monestier, M. et al., Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J. Immunol. 2009. 183: 3109-3117.
59. Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J. andMarshak-Rothstein, A., Activation of autoreactive B cells by CpG dsDNA. Immunity 2003. 19: 837-847.
60. Yasuda, K., Richez, C., Maciaszek, J. W., Agrawal, N., Akira, S., Marshak-Rothstein, A.and Rifkin, I. R., Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF-5 and IRF-7 dependent and is required for IL-6 production. J. Immunol. 2007. 178: 6876-6885.